767
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Application of HIPEC simulations for optimizing treatment delivery strategies

, , , , , , , & show all
Article: 2218627 | Received 28 Feb 2023, Accepted 22 May 2023, Published online: 16 Jul 2023

References

  • Li X-F, Carlin S, Urano M, et al. Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy. Cancer Res. 2007;67(16):7646–7653.
  • Verwaal V, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737–3743.
  • Baronzio GF, Seta RD, D’Amico M, et al. Effects of local and whole body hyperthermia on immunity. Austin (TX): Landes Bioscience; 2000–2013.
  • Helderman RF, Löke DR, Verhoeff J, et al. The temperature-dependent effectiveness of platinum-based drugs mitomycin-c and 5-fu during hyperthermic intraperitoneal chemotherapy (hipec) in colorectal cancer cell lines. Cells. 2020;9(8):1775.
  • Oei AL, Vriend LEM, Crezee J, et al. Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all. Radiat Oncol. 2015;10:165.
  • Overgaard J. Formula to estimate the thermal enhancement ratio of a single simultaneous hyperthermia and radiation treatment. Acta Radiol Oncol. 1984;23(2–3):135–139.
  • Urano M, Ling CC. Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro. Int J Hyperthermia. 2002;18(4):307–315.
  • Rettenmaier MA, Mendivil AA, Gray CM, et al. Intra-abdominal temperature distribution during consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of advanced stage ovarian carcinoma. Int J Hyperthermia. 2015;31(4):396–402.
  • Ceelen W, De Somer F, Van Nieuwenhove Y, et al. Effect of perfusion temperature on glucose and electrolyte transport during hyperthermic intraperitoneal chemoperfusion (HIPEC) with oxaliplatin. Eur J Surg Oncol. 2013;39(7):754–759.
  • Schaaf L, van der Kuip H, Zopf W, et al. A temperature of 40 °C appears to be a critical threshold for potentiating cytotoxic chemotherapy in vitro and in peritoneal carcinomatosis patients undergoing HIPEC. Ann Surg Oncol. 2015;22(Suppl 3):S758–S765.
  • Quénet F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256–266.
  • Yarmolenko PS, Moon EJ, Landon C, et al. Thresholds for thermal damage to normal tissues: an update. Int J Hyperthermia. 2011;27(4):320–343.
  • Lindegaard JC, Grau C, Overgaard J. Effect of step-down heating on the interaction between heat and radiation in a C3H mammary carcinoma in vivo. Int J Radiat Biol. 1991;60(4):707–721. PMID: 1680149.
  • Hiraoka M, Miyakoshi J, Jo S, et al. Effects of step-up and step-down heating on a transplantable murine tumor. Jpn J Cancer Res. 1986;77(11):1102–1106.
  • Jones EL, Douple EB. Effect of step-down heating on brachytherapy in a murine tumor system. Radiat Res. 1990;124(2):141–146.
  • Weller HG, Tabor G, Jasak H, et al. A tensorial approach to computational continuum mechanics using object-oriented techniques. Comput Phys. 1998;12(6):620–631.
  • Löke DR, Helderman RFCPA, Sijbrands J, et al. A four-inflow construction to ensure thermal stability and uniformity during hyperthermic intraperitoneal chemotherapy (HIPEC) in rats. Cancers. 2020;12(12):3516.
  • Löke DR, Helderman RFCPA, Rodermond HM, et al. Demonstration of treatment planning software for hyperthermic intraperitoneal chemotherapy in a rat model. Int J Hyperthermia. 2021;38(1):38–54.
  • Löke DR, Kok HP, Helderman RFCPA, et al. Validation of thermal dynamics during hyperthermic intraperitoneal chemotherapy simulations using a 3D-printed phantom. Front Oncol. 2023;13:1102242
  • OpenFoamWiki. 2020. Available from: https://openfoamwiki.net/index.php/chtmultiregionfoam.
  • Hasgall P, Di Gennaro F, Baumgartner C, et al. IT’IS database for thermal and electromagnetic parameters of biological tissues. Version 4.1, February 22. 2022.
  • Valvano JW. Bioheat transfer. In: Encyclopedia of medical devices and instrumentation. New Jersy: John Wiley; 2006.
  • Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res. 1987;47(12):3039–3051.
  • Nakamura Y, Wayland H. Macromolecular transport in the cat mesentery. Microvasc Res. 1975;9(1):1–21.
  • Baxter LT, Jain RK. Transport of fluid and macromolecules in tumors I. Role of interstitial pressure and convection. Microvasc Res. 1989;37(1):77–104.
  • Steuperaert M, Labate GFD, Debbaut C, et al. Mathematical modeling of intraperitoneal drug delivery: simulation of drug distribution in a single tumor nodule. Drug Deliv. 2017;24(1):491–501.
  • Mahteme H, Wallin I, Glimelius B, et al. Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion. Eur J Clin Pharmacol. 2008;64(9):907–911.
  • Sessler D. Perioperative heat balance. Anesthesiology. 2000;92(2):578–596.
  • Segars WP, Sturgeon G, Mendonca S, et al. 4D XCAT phantom for multimodality imaging research. Med Phys. 2010;37(9):4902–4915.
  • Ackerman MJ. The visible human project: a resource for anatomical visualization. Stud Health Technol Inform. 1998;52(Pt 2):1030–1032.
  • de Jong LAW, Elekonawo FMK, Lambert M, et al. Wide variation in tissue, systemic, and drain fluid exposure after oxaliplatin-based HIPEC: results of the GUTOX study. Cancer Chemother Pharmacol. 2020;86(1):141–150.
  • The OpenFOAM Foundation. OpenFOAM user guide Vol. v2112. Berkshire, England: OFBC; 2022. Available from: https://www.openfoam.com/documentation/guides/latest/doc/index.html
  • Goldenshluger M, Zippel D, Ben-Yaacov A, et al. Core body temperature but not intraabdominal pressure predicts postoperative complications following closed-system hyperthermic intraperitoneal chemotherapy (HIPEC) administration. Ann Surg Oncol. 2018;25(3):660–666.
  • Hendrix RJ, Kassira JP, Lambert LA. Elevated maximum core body temperature during hyperthermic intraperitoneal chemoperfusion (HIPEC) is associated with increased postoperative complications. Ann Surg Oncol. 2020;27(1):232–239.
  • Ba M, Cui S, Long H, et al. Safety and effectiveness of high-precision hyperthermic intraperitoneal perfusion chemotherapy in peritoneal carcinomatosis: a real-world study. Front. Oncol. 2021;11:674915
  • Kamal JM, Elshaikh SM, Nabil D, et al. The perioperative course and anesthetic challenge for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Egypt J Anaesth. 2013;29(4):311–318.
  • Halkia E, Tsochrinis A, Vassiliadou D, et al. Peritoneal carcinomatosis: intraoperative parameters in open (coliseum) versus closed abdomen HIPEC. Int J Surg Oncol. 2015;2015:610597.
  • Schooneveldt G, Löke DR, Zweije R, et al. Experimental validation of a thermophysical fluid model for use in a hyperthermia treatment planning system. Int J Heat Mass Transf. 2020;152:119495.
  • ASME. Assessing credibility of computational modeling through verification and validation: application to medical devices. ASME Standard, V&V 40. New York (NY): American Society of Mechanical Engineers; 2018.
  • van Rhoon GC, Samaras T, Yarmolenko PS, et al. Cem43 °c thermal dose thresholds: a potential guide for magnetic resonance radiofrequency exposure levels? Eur Radiol. 2013;23(8):2215–2227.
  • Petersen EK, Bue M, Harlev C, et al. Abdominal tissue concentrations and penetration of carboplatin in a HIPEC procedure – assessment in a novel porcine model. Pleura Peritoneum. 2022;7(3):117–125.
  • Koemans W, van der Kaaij R, Wassenaar E, et al. Systemic exposure of oxaliplatin and docetaxel in gastric cancer patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy. Eur J Surg Oncol. 2021;47(2):486–489.
  • Zivanovic O, Abramian A, Kullmann M, et al. HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer. Int J Cancer. 2015;136(3):699–708.